State Street Corp Uro Gen Pharma Ltd. Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, State Street Corp holds 769,583 shares of URGN stock, worth $8.19 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

769,583

Previous 726,676 5.9%

Holding current value

$8.19 Million

Previous $12.2 Million 19.85%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$12.7 - $17.92 $544,918 - $768,893	42,907 Added 5.9%	769,583 $9.77 Million
Q2 2024 Aug 14, 2024	BUY	$12.72 - $19.2 $2.41 Million - $3.64 Million	189,682 Added 35.32%	726,676 $12.2 Million
Q1 2024 May 15, 2024	BUY	$13.81 - $19.33 $637,511 - $892,330	46,163 Added 9.41%	536,994 $8.05 Million
Q4 2023 Feb 14, 2024	BUY	$10.87 - $15.93 $399,222 - $585,061	36,727 Added 8.09%	490,831 $7.36 Million
Q3 2023 Nov 14, 2023	BUY	$8.84 - $22.64 $309,921 - $793,735	35,059 Added 8.37%	454,104 $6.36 Million
Q2 2023 Aug 14, 2023	BUY	$8.75 - $14.29 $2.61 Million - $4.27 Million	298,823 Added 248.56%	419,045 $4.34 Million
Q1 2023 May 15, 2023	BUY	$7.99 - $11.02 $60,979 - $84,104	7,632 Added 6.78%	120,222 $1.11 Million
Q4 2022 Feb 14, 2023	BUY	$7.55 - $11.96 $75,560 - $119,695	10,008 Added 9.76%	112,590 $998,000
Q3 2022 Nov 15, 2022	SELL	$7.21 - $9.41 $238,211 - $310,896	-33,039 Reduced 24.36%	102,582 $853,000
Q2 2022 Aug 15, 2022	SELL	$5.12 - $8.74 $2.11 Million - $3.61 Million	-412,620 Reduced 75.26%	135,621 $1.11 Million
Q1 2022 May 16, 2022	BUY	$5.92 - $9.73 $247,965 - $407,550	41,886 Added 8.27%	548,241 $4.78 Million
Q4 2021 Feb 14, 2022	SELL	$9.03 - $19.13 $48,500 - $102,747	-5,371 Reduced 1.05%	506,355 $4.82 Million
Q3 2021 Nov 15, 2021	BUY	$14.31 - $18.39 $493,237 - $633,866	34,468 Added 7.22%	511,726 $8.61 Million
Q2 2021 Aug 16, 2021	BUY	$15.2 - $20.94 $545,968 - $752,143	35,919 Added 8.14%	477,258 $7.29 Million
Q1 2021 May 17, 2021	BUY	$17.99 - $26.96 $16,694 - $25,018	928 Added 0.21%	441,339 $8.6 Million
Q4 2020 Feb 16, 2021	BUY	$17.54 - $25.43 $472,545 - $685,109	26,941 Added 6.52%	440,411 $7.94 Million
Q3 2020 Nov 10, 2020	SELL	$18.81 - $26.42 $220,660 - $309,933	-11,731 Reduced 2.76%	413,470 $7.98 Million
Q2 2020 Aug 14, 2020	BUY	$16.5 - $29.7 $479,424 - $862,963	29,056 Added 7.33%	425,201 $11.1 Million
Q1 2020 May 11, 2020	BUY	$13.68 - $34.6 $5.42 Million - $13.7 Million	396,145 New	396,145 $7.07 Million

Others Institutions Holding URGN

# of Institutions

130

Shares Held

35.9M

Call Options Held

22K

Put Options Held

93.8K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $242M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Uro Gen Pharma Ltd. Transaction History